Status:
TERMINATED
Preoperative Use of Darifenacin (Enablex) to Alleviate Postoperative Ureteral Stent Pain
Lead Sponsor:
University of Missouri-Columbia
Conditions:
Overactive Bladder
Renal Colic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This will be a randomized two arm prospective study to evaluate postoperative ureteral stent pain. One arm will be given 3 days of preoperative darifenacin and the control group will have the standard...
Detailed Description
The purpose of the study is to determine if preoperative dosing of darifenacin will assist in postoperative ureteral stent pain. This will be a randomized two arm prospective study to evaluate postope...
Eligibility Criteria
Inclusion
- Participants will be included in the study if they are undergoing a procedure that a stent will likely be required. This will include participants who will have ureteroscopy or extracorporeal shock wave lithotripsy and a stone 1 cm or larger.
- Also participants with stones smaller than 1 cm who due to anatomy of the ureter or kidney will likely need a stent on preoperative evaluation will also be included in the study.
- Included as well in the study are participants who will undergo renal or ureteral surgery that a ureteral stent will be utilized.
Exclusion
- Those who do not meet inclusion criteria-
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT01189071
Start Date
August 1 2009
End Date
July 1 2011
Last Update
November 21 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Missouri Healthcare
Columbia, Missouri, United States, 65212